companydata.dkcompanydata.dk

Signum Life Science ApS: Financial statements 2024

CVR: 36559241

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Signum Life Science ApS (CVR 36559241) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -1,866,160 and a net result of DKK -5,936,982 compared with DKK -3,084,293 the year before. Equity in the 2024 report amounted to DKK 106,811,126. The solvency ratio was 85%. The company had 41 employees in the financial year.

Gross Profit
DKK -1,866,160
Profit/Loss
DKK -5,936,982
Equity
DKK 106,811,126
Total Assets
DKK 125,589,542
Employees
41

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--1.9M-5.9M106.8M41
2023-1.5M-3.1M112.7M41
2022--184K-11.3M115.8M36
2021-7.6M1.3M128.5M34
2020-8.1M1M128.2M32

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Signum Life Science ApS: The 2023 annual report is outMay 14, 2024

Signum Life Science ApS has published its annual report for 2023. Gross profit came to DKK 1,482,298, and the net result was DKK -3,084,293.

Søren Hvidsten Nielsen joins the board of Signum Life Science ApSApr 20, 2024

As of April 20, 2024, Søren Hvidsten Nielsen has joined the board of directors of Signum Life Science ApS.

Christian Bruun-Andersen joins the board of Signum Life Science ApSApr 20, 2024

As of April 20, 2024, Christian Bruun-Andersen has joined the board of directors of Signum Life Science ApS.

Felicia Nina Ida Salicath joins the board of Signum Life Science ApSApr 20, 2024

As of April 20, 2024, Felicia Nina Ida Salicath has joined the board of directors of Signum Life Science ApS.

Anne Marie Hedegaard Byskov joins the board of Signum Life Science ApSApr 20, 2024

As of April 20, 2024, Anne Marie Hedegaard Byskov has joined the board of directors of Signum Life Science ApS.

Anne Cathrine Falch-Jørgensen joins the board of Signum Life Science ApSApr 20, 2024

As of April 20, 2024, Anne Cathrine Falch-Jørgensen has joined the board of directors of Signum Life Science ApS.

Thomas Gross Nødvig leaves the board of Signum Life Science ApSApr 20, 2024

As of April 20, 2024, Thomas Gross Nødvig has left the board of directors of Signum Life Science ApS.

Pia Krogsgaard Villadsen leaves the board of Signum Life Science ApSApr 20, 2024

As of April 20, 2024, Pia Krogsgaard Villadsen has left the board of directors of Signum Life Science ApS.

Signum Life Science ApS appoints new auditorApr 19, 2024

As of April 19, 2024, EY Godkendt Revisionspartnerselskab has been appointed auditor of Signum Life Science ApS.

Auditor steps down at Signum Life Science ApSApr 19, 2024

As of April 19, 2024, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Signum Life Science ApS.

About Signum Life Science ApS

Signum Life Science ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2015. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named DLI Market Intelligence ApS. The management consists of Thomas Senderovitz. The board consists of Anja Cecilie Verhaug (chair), Mari-Ann Retz, Anne Marie Hedegaard Byskov and Søren Hvidsten Nielsen. The company is owned by DLI - DANSK LÆGEMIDDEL INFORMATION A/S and TJELLESEN MAX JENNE A/S. The company has 53 employees (2026). In 2025, the company reported a gross profit of DKK -67,441,461 and a net result of DKK -66,049,966 compared with DKK -5,936,982 the year before. Equity in the 2025 report amounted to DKK 40,680,589.

Source: annual report 2025, Danish Business Authority